263 related articles for article (PubMed ID: 12548199)
1. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
Arici A; Sozen I
Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
[TBL] [Abstract][Full Text] [Related]
2. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
Senturk LM; Sozen I; Gutierrez L; Arici A
Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
[TBL] [Abstract][Full Text] [Related]
4. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
5. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
Chegini N; Tang XM; Ma C
J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
[TBL] [Abstract][Full Text] [Related]
6. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
9. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro.
Rossi MJ; Chegini N; Masterson BJ
Endocrinology; 1992 Mar; 130(3):1716-27. PubMed ID: 1311246
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata.
Liang M; Wang H; Zhang Y; Lu S; Wang Z
Cancer Biol Ther; 2006 Jan; 5(1):28-33. PubMed ID: 16294022
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor and transforming growth factor-beta in uterine fibroids and myometrium.
Vollenhoven BJ; Herington AC; Healy DL
Gynecol Obstet Invest; 1995; 40(2):120-4. PubMed ID: 8575689
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
Shimomura Y; Matsuo H; Samoto T; Maruo T
J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation.
Arici A; Sozen I
Fertil Steril; 2000 May; 73(5):1006-11. PubMed ID: 10785229
[TBL] [Abstract][Full Text] [Related]
16. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma.
Park JY; Chae B; Kim MR
Int J Med Sci; 2022; 19(12):1779-1786. PubMed ID: 36313223
[No Abstract] [Full Text] [Related]
18. The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro.
Tang XM; Dou Q; Zhao Y; McLean F; Davis J; Chegini N
Mol Hum Reprod; 1997 Mar; 3(3):233-40. PubMed ID: 9237249
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
20. Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1.
Zhou W; Park I; Pins M; Kozlowski JM; Jovanovic B; Zhang J; Lee C; Ilio K
Endocrinology; 2003 Oct; 144(10):4280-4. PubMed ID: 12959966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
